Publisher Correction: LINC317.5 as a novel biomarker for hypertriglyceridemia in abnormal glucose metabolism
Yixue Yang, Mengzi Sun, Shoumeng Yan, Nan Yao, Xiaotong Li, Caihong Wu, Zibo Wu, Fengdan Wang, Weiwei Cui, Bo Li
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLipid metabolism and disorders · Cancer, Lipids, and Metabolism
Correction to: Cell Death Discovery 10.1038/s41420-024-01968-7, published online 26 April 2024
In this article the article title has been given erroneously:
“LINC317.5 as a Novel Biomarker for Hypertriglyceridemia in Normal Glucose Metabolism”
It should read:
“LINC317.5 as a Novel Biomarker for Hypertriglyceridemia in Abnormal Glucose Metabolism”
The original article has been updated.